Showing results (1841-1850 of 1,910) with videos related to
Sort By:
Pageof 191
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.Nature|May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencingVolker Hovestadt, David T W Jones, Simone Picelli, et al.Nature Cancer|May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactionsAlexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.Neurobiology of Aging|October 22, 2018
Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohortGijs H P Tazelaar, Annelot M Dekker, Joke J F A van Vugt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation CohortMartin Mynarek, Katja von Hoff, Torsten Pietsch, et al.Brain Communications|September 21, 2020
ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalizationGijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, et al.Science Translational Medicine|October 6, 2021
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomasPooja Panwalkar, Benita Tamrazi, Derek Dang, et al.Nature|March 12, 2026
Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.Cancer Research|October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for MedulloblastomaJessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.Pageof 191